Platelet Aggregation Devices Market Report 2025

This Platelet Aggregation Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The platelet aggregation devices market size has grown exponentially in recent years. It will grow from $0.83 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 25.8%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rising incidences of bleeding disorders, growing awareness about health diagnostics, increase in surgical procedures, improved diagnostic accuracy.

The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.59 billion in 2029 at a compound annual growth rate (CAGR) of 25.4%. The growth in the forecast period can be attributed to growing aging population, rising demand for point-of-care testing, expansion of personalized medicine, regulatory support and approvals, increasing prevalence of chronic diseases. Major trends in the forecast period include integration of artificial intelligence in diagnostics, development of portable platelet aggregation devices, increased collaboration between biotech firms and healthcare providers, rising importance of data analytics in healthcare, shift towards home-based diagnostics.

The platelet aggregation devices market is poised for growth, driven by the increasing prevalence of target diseases, which are significant medical conditions that require focused prevention, diagnosis, and treatment efforts, such as cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices play a crucial role in reducing the incidence of target diseases by facilitating early detection and effective management of thrombotic risks, thereby preventing complications such as heart attacks and strokes in vulnerable populations. For example, as of February 2024, the International Agency for Research on Cancer (IARC) reported approximately 20 million new cancer cases and 9.7 million deaths globally in 2022, with projections indicating a substantial increase in new cases by 2050. This rise in target diseases is a key driver for the platelet aggregation devices market.

Leading companies in the platelet aggregation devices sector are intensifying their efforts to develop advanced solutions by introducing innovative products such as the first platelet pooling set designed to stabilize the U.S. platelet supply and address growing demands. A platelet pooling set is a specialized medical device used during plateletpheresis procedures to collect and concentrate platelets from multiple donors into a single unit for transfusion therapy. For instance, in February 2023, TERUMO BCT INC. announced the FDA approval of the IMUGARD WB Platelet Pooling Set, offering extended shelf life, seven-day storage clearance, and enabling platelet recoupment from whole blood donations. This advancement improves platelet availability, supply management efficiency, and supports critical medical procedures such as chemotherapy and organ transplants.

In August 2023, Cell Microsystems acquired Fluxion Biosciences Inc., expanding the platelet aggregation devices market with advanced systems such as IonFlux, BioFlux, and IsoFlux, integrating automated patch clamp technology for cellular electrophysiology, and providing tools for live cell assays and platelet aggregation studies. Fluxion Biosciences Inc. specializes in automating complex assays, including platelet aggregation and thrombus formation, further enhancing the market's capabilities.

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago.

North America was the largest region in the platelet aggregation devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the platelet aggregation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Platelet aggregation devices are specialized tools utilized to measure the rate and extent of platelet clumping, a critical aspect in diagnosing and managing blood clotting disorders. These devices play a key role in evaluating the efficacy of antiplatelet therapies, diagnosing bleeding disorders, and assessing platelet function across various clinical and research environments.

The primary types of platelet aggregation devices include reagents, systems, consumables, and accessories. Reagents are substances employed in laboratory experiments to induce platelet aggregation, aiding in the diagnosis of blood clotting disorders. Each reagent serves a specific function, contributing to precise analysis and treatment planning. These devices may feature different channel configurations such as four channels, dual channels, or eight channels, and utilize technologies such as optical, impedance, and others. They find application in clinical settings, research endeavors, cardiovascular assessments, orthopedic evaluations, and more. End users of these devices include standalone hospitals, diagnostic laboratories, research and academic institutes, and other relevant entities.

The platelet aggregation devices market research report is one of a series of new reports that provides platelet aggregation devices market statistics, including platelet aggregation devices industry global market size, regional shares, competitors with a platelet aggregation devices market share, detailed platelet aggregation devices market segments, market trends and opportunities, and any further data you may need to thrive in the platelet aggregation devices industry. This platelet aggregation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The platelet aggregation devices market consists of revenues earned by entities by providing services such as calibration and maintenance services, device training and education programs, data management and analysis services, remote monitoring and technical support, customization and integration services, and regulatory compliance consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The platelet aggregation devices market also includes sales of products such as laser-based aggregometers, microfluidic devices, biosensor-based aggregation analyzers, point-of-care platelet function analyzers, fluorescence-based aggregation systems, and nanotechnology-enhanced platelet testing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.